Electronic transmission of prescriptions in primary care: transformation, timing and teamwork
Chloë Campbell 1 2 , Caroline Morris 1 , Lynn McBain 11 Department of Primary Health Care and General Practice, University of Otago, Wellington, New Zealand.
2 Corresponding author. Email: chloecampbell@mail.com
Journal of Primary Health Care 13(4) 340-350 https://doi.org/10.1071/HC21050
Published: 23 December 2021
Journal Compilation © Royal New Zealand College of General Practitioners 2021 This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
Abstract
INTRODUCTION: During the coronavirus disease 2019 (COVID-19) pandemic lockdown in New Zealand in March 2020, there was a rapid shift to virtual consultations in primary care. This change was supported by system adjustments to enable electronic transmission of prescriptions without a handwritten signature if they met certain security criteria. International research suggests potential for unintended consequences with such changes, so it is important to understand the effect on professional practice in New Zealand general practice and community pharmacy.
AIM: The purpose of this study was to undertake a preliminary exploration of the experiences of New Zealand general practitioners and community pharmacists when prescriptions are transmitted electronically directly from prescriber to pharmacy.
METHODS: Semi-structured interviews with a purposive sample of four pharmacists and four general practitioners gathered qualitative data about their experiences of the shift to electronic transmission of prescriptions. Participants’ perceptions of effect on professional workflow, interprofessional interactions between general practitioners and pharmacists, and interactions with patients were explored. Interviews were audio-recorded, and the data analysed thematically using an inductive approach.
RESULTS: Four themes were identified: workflow transformation; mixed impact on interactions with patients; juggling timing and expectations; and new avenues for interprofessional communication (with some cul-de-sacs).
DISCUSSION: Both general practitioners and pharmacists experienced transformational changes to workflow. This was positive for general practitioners due to saved time and increased work flexibility. Pharmacists noted potential benefits but also some challenges. To fully reap teamwork benefits, more work is needed on managing the timing issues and patient expectations, and to refine the new modes of communication between health-care practitioners.
KEYwords: General practice; community pharmacies; primary health care; telemedicine; electronic prescribing, workflow.
References
[1] Bruthans J. The state of national electronic prescription systems in the EU in 2018 with special consideration given to interoperability issues. Int J Med Inform. 2020; 141 104205.| The state of national electronic prescription systems in the EU in 2018 with special consideration given to interoperability issues.Crossref | GoogleScholarGoogle Scholar | 32492586PubMed |
[2] Aldughayfiq B, Sampalli S. Digital health in physicians’ and pharmacists’ office: a comparative study of e-prescription systems’ architecture and digital security in eight countries. OMICS. 2021; 25 102–22.
| Digital health in physicians’ and pharmacists’ office: a comparative study of e-prescription systems’ architecture and digital security in eight countries.Crossref | GoogleScholarGoogle Scholar | 32931378PubMed |
[3] Health Information and Quality Authority. E-prescribing and electronic transfer of prescriptions: an international review. 2012. [cited 2021 April 1]. Available from: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.470.2747&rep=rep1&type=pdf
[4] Ministry of Health. eMedicines. Wellington: Ministry of Health. [cited 2021 April 1]. Available from: www.health.govt.nz/our-work/digital-health/other-digital-health-initiatives/emedicines
[5] Ministry of Health. New Zealand e-Prescription Service. Wellington: Ministry of Health. [cited 2021 April 1]. Available from: www.health.govt.nz/our-work/digital-health/other-digital-health-initiatives/emedicines/new-zealand-eprescription-service
[6] Ministry of Health. Signature Exempt Prescriptions – Frequently Asked Questions. Wellington: Ministry of Health. [cited 2021 April 1]. Available from: www.health.govt.nz/our-work/digital-health/other-digital-health-initiatives/emedicines/new-zealand-eprescription-service/signature-exempt-prescriptions-and-remote-prescribing
[7] Nanji KC, Rothschild JM, Boehne JJ, et al. Unrealized potential and residual consequences of electronic prescribing on pharmacy workflow in the outpatient pharmacy. J Am Med Inform Assoc. 2014; 21 481–6.
| Unrealized potential and residual consequences of electronic prescribing on pharmacy workflow in the outpatient pharmacy.Crossref | GoogleScholarGoogle Scholar | 24154836PubMed |
[8] Gilligan AM, Miller K, Mohney A, et al. Analysis of pharmacists’ interventions on electronic versus traditional prescriptions in 2 community pharmacies. Res Social Adm Pharm. 2012; 8 523–32.
| Analysis of pharmacists’ interventions on electronic versus traditional prescriptions in 2 community pharmacies.Crossref | GoogleScholarGoogle Scholar | 22264963PubMed |
[9] Lanham AE, Cochran GL, Klepser DG. Electronic prescriptions: opportunities and challenges for the patient and pharmacist. Adv Health Care Technol. 2016; 2 1–11.
[10] Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006; 3 77–101.
| Using thematic analysis in psychology.Crossref | GoogleScholarGoogle Scholar |
[11] Odukoya OK, Chui MA. E-prescribing: a focused review and new approach to addressing safety in pharmacies and primary care. Res Social Adm Pharm. 2013; 9 996–1003.
| E-prescribing: a focused review and new approach to addressing safety in pharmacies and primary care.Crossref | GoogleScholarGoogle Scholar | 23062769PubMed |
[12] Odukoya OK, Chui MA. Relationship between e-prescriptions and community pharmacy workflow. J Am Pharm Assoc. 2012; 52 e168–74.
| Relationship between e-prescriptions and community pharmacy workflow.Crossref | GoogleScholarGoogle Scholar |
[13] Napier P, Norris P, Braund R. Introducing a checking technician allows pharmacists to spend more time on patient focused activities. Res Social Adm Pharm. 2018; 14 382–6.
| Introducing a checking technician allows pharmacists to spend more time on patient focused activities.Crossref | GoogleScholarGoogle Scholar | 28511852PubMed |
[14] Brown CLR, Slee K, Coleman A, et al. A literature review of the training offered to qualified prescribers to use electronic prescribing systems: why is it so important? Int J Pharm Pract. 2017; 25 195–202.
| A literature review of the training offered to qualified prescribers to use electronic prescribing systems: why is it so important?Crossref | GoogleScholarGoogle Scholar |
[15] Kivekäs E, Enlund H, Borycki E, Saranto K. General practitioners’ attitudes towards electronic prescribing and the use of the national prescription centre. J Eval Clin Pract. 2016; 22 816–25.
| General practitioners’ attitudes towards electronic prescribing and the use of the national prescription centre.Crossref | GoogleScholarGoogle Scholar | 27121026PubMed |
[16] Zaresani A, Scott A. Does digital health technology improve physicians’ job satisfaction and work–life balance? A cross-sectional national survey and regression analysis using an instrumental variable. BMJ Open. 2020; 10 e041690.
| Does digital health technology improve physicians’ job satisfaction and work–life balance? A cross-sectional national survey and regression analysis using an instrumental variable.Crossref | GoogleScholarGoogle Scholar | 33310807PubMed |
[17] Schleiden LJ, Odukoya OK, Chui MA. Older adults’ perceptions of e-prescribing: Impact on patient care. Perspect Health Inf Manag. 2015; 12 1d.
| 26807076PubMed |
[18] Imlach F, McKinlay E, Middleton L, et al. Telehealth consultations in general practice during a pandemic lockdown: survey and interviews on patient experiences and preferences. BMC Fam Pract. 2020; 21 269.
| Telehealth consultations in general practice during a pandemic lockdown: survey and interviews on patient experiences and preferences.Crossref | GoogleScholarGoogle Scholar | 33308161PubMed |
[19] Health Quality and Safety Commission. A survey of patient experience in New Zealand during the first COVID-19 lockdown. [cited 2021 April 1]. Available from: www.hqsc.govt.nz/our-programmes/health-quality-evaluation/projects/patient-experience/covid-19-patient-experience-survey/survey-results/
[20] Frail CKK, Snyder ME. Patient perceptions of e-prescribing and its impact on their relationships with providers: a qualitative analysis. J Am Pharm Assoc. 2014; 54 630–3.
| Patient perceptions of e-prescribing and its impact on their relationships with providers: a qualitative analysis.Crossref | GoogleScholarGoogle Scholar |
[21] Hikaka J, Jones R, Hughes C, Martini N. “It is through shared conversation, that I understand”—Māori older adults’ experiences of medicines and related services in Aotearoa New Zealand. N Z Med J. 2020; 133 33–46.
| 32525860PubMed |
[22] Sansgiry SS, Bhansali AH, Mhatre SK, Sawant RV. Influence of patient perceived relationship with pharmacist and physician and its association with beliefs in medicine. J Pharm Health Serv Res. 2017; 8 123–30.
| Influence of patient perceived relationship with pharmacist and physician and its association with beliefs in medicine.Crossref | GoogleScholarGoogle Scholar |
[23] Vicary D, Hutchison C, Aspden T. Avoiding acute kidney injury in primary care: attitudes and behaviours of general practitioners and community pharmacists in Hawke’s Bay. J Prim Health Care. 2020; 12 244–56.
| Avoiding acute kidney injury in primary care: attitudes and behaviours of general practitioners and community pharmacists in Hawke’s Bay.Crossref | GoogleScholarGoogle Scholar | 32988446PubMed |
[24] Vicary D, Hutchison C, Aspden T. Demonstrating the value of community pharmacists in New Zealand educating a targeted group of people to temporarily discontinue medicines when they are unwell to reduce the risk of acute kidney injury. Int J Pharm Pract. 2020; 28 569–78.
| Demonstrating the value of community pharmacists in New Zealand educating a targeted group of people to temporarily discontinue medicines when they are unwell to reduce the risk of acute kidney injury.Crossref | GoogleScholarGoogle Scholar | 32945014PubMed |
[25] Whaley C, Bancsi A, Ho JM-W, et al. Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis. BMC Health Serv Res. 2021; 21 89.
| Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis.Crossref | GoogleScholarGoogle Scholar | 33499869PubMed |
[26] Smith M, Sprecher B. Pharmacy communications with physician offices to clarify prescriptions. J Am Pharm Assoc. 2017; 57 178–82.
| Pharmacy communications with physician offices to clarify prescriptions.Crossref | GoogleScholarGoogle Scholar |
[27] Trausch N, Green JA. Direct observation of telephone communication between community pharmacies and prescribers in New Zealand. Int J Clin Pharm. 2018; 40 1005–9.
| Direct observation of telephone communication between community pharmacies and prescribers in New Zealand.Crossref | GoogleScholarGoogle Scholar | 30051229PubMed |
[28] Löffler C, Koudmani C, Böhmer F, et al. Perceptions of interprofessional collaboration of general practitioners and community pharmacists – a qualitative study. BMC Health Serv Res. 2017; 17 224.
| Perceptions of interprofessional collaboration of general practitioners and community pharmacists – a qualitative study.Crossref | GoogleScholarGoogle Scholar | 28327136PubMed |
[29] Bugnon B, Geissbuhler A, Bischoff T, et al. Improving primary care medication processes by using shared electronic medication plans in Switzerland: lessons learned from a participatory action research study. JMIR Form Res. 2021; 5 e22319.
| Improving primary care medication processes by using shared electronic medication plans in Switzerland: lessons learned from a participatory action research study.Crossref | GoogleScholarGoogle Scholar | 33410753PubMed |
